Verition Fund Management
EVAR

Verition Fund Management’s Lombard Medical, Inc. EVAR Stock Holding History

Verition Fund Management’s Portfolio EVAR Stock Details EVAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-19,129
Closed -$8K – 1414
2017
Q3 		$8K Hold
19,129
– – ﹤0.01% 1129
2017
Q2 		$11K Hold
19,129
– – ﹤0.01% 885
2017
Q1 		$15K Buy
+19,129
New +$12.5K ﹤0.01% 1133
2016
Q4 		– Sell
-19,129
Closed -$18K – 1544
2016
Q3 		$18K Hold
19,129
– – ﹤0.01% 1105
2016
Q2 		$21K Hold
19,129
– – ﹤0.01% 858
2016
Q1 		$20K Hold
19,129
– – ﹤0.01% 688
2015
Q4 		$26K Hold
19,129
– – 0.01% 410
2015
Q3 		$70K Hold
19,129
– – 0.02% 486
2015
Q2 		$84K Sell
19,129
-24,467
-56% -$112K 0.01% 561
2015
Q1 		$176K Buy
43,596
+13,694
+46% +$70.5K 0.02% 326
2014
Q4 		$194K Buy
29,902
+805
+3% +$5.28K 0.04% 250
2014
Q3 		$224K Buy
29,097
+4,987
+21% +$33K 0.03% 528
2014
Q2 		$174K Buy
+24,110
New +$196K 0.02% 566

Other funds holding EVAR

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Verition Fund Management's EVAR Position: Q4 2017 in Review

Verition Fund Management sold out of Lombard Medical, Inc. (EVAR) in Q4 2017, closing a stake of 19,129 shares — an estimated $8K sold.

Verition Fund Management first reported a position in EVAR in Q2 2014 and held it in 13 quarters. The position peaked at $224K in Q3 2014. 2 funds tracked by Wall St. Rank hold EVAR as of Q4 2017.

  • Verition Fund Management reported no remaining Lombard Medical, Inc. position as of Q4 2017 after selling out during the quarter.
  • Verition Fund Management sold 19,129 Lombard Medical, Inc. shares in Q4 2017, an estimated $8K.
  • Verition Fund Management first reported a position in Lombard Medical, Inc. in Q2 2014 and held it in 13 quarters.
  • Verition Fund Management's Lombard Medical, Inc. position peaked at $224K in Q3 2014.
  • 2 funds tracked by Wall St. Rank held Lombard Medical, Inc. as of Q4 2017.

Based on Verition Fund Management's 13F filing for Q4 2017, filed 15 Feb 2018.